Capital International Sarl Crispr Therapeutics Ag Transaction History

Capital International Sarl

$3.71 Billion
Q3 2024

A detailed history of Capital International Sarl transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Capital International Sarl holds 170,523 shares of CRSP stock, worth $6.82 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

170,523

Previous 149,393 14.14%

Holding current value

$6.82 Million

Previous $8.07 Million 0.69%

% of portfolio

0.22%

Previous 0.26%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$44.62 - $62.75 $942,820 - $1.33 Million	21,130 Added 14.14%	170,523 $8.01 Million
Q2 2024 Aug 13, 2024	BUY	$51.17 - $68.18 $383,007 - $510,327	7,485 Added 5.27%	149,393 $8.07 Million
Q1 2024 May 14, 2024	BUY	$60.67 - $89.12 $2.38 Million - $3.5 Million	39,234 Added 38.21%	141,908 $9.67 Million
Q4 2023 Feb 13, 2024	BUY	$38.62 - $72.18 $406,707 - $760,127	10,531 Added 11.43%	102,674 $6.43 Million
Q3 2023 Nov 13, 2023	BUY	$45.39 - $59.0 $304,476 - $395,772	6,708 Added 7.85%	92,143 $4.18 Million
Q2 2023 Aug 11, 2023	BUY	$43.47 - $67.77 $350,498 - $546,429	8,063 Added 10.42%	85,435 $4.8 Million
Q1 2023 May 15, 2023	BUY	$41.0 - $56.12 $773,055 - $1.06 Million	18,855 Added 32.22%	77,372 $3.5 Million
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $337,817 - $566,075	8,620 Added 17.28%	58,517 $2.38 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $1.14 Million - $1.56 Million	18,618 Added 59.52%	49,897 $3.26 Million
Q2 2022 Aug 15, 2022	BUY	$43.23 - $73.83 $306,500 - $523,454	7,090 Added 29.31%	31,279 $1.9 Million
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $214,196 - $319,099	4,027 Added 19.97%	24,189 $1.52 Million
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $1.14 Million - $1.81 Million	16,234 Added 413.29%	20,162 $1.53 Million
Q3 2021 Nov 15, 2021	SELL	$110.2 - $156.64 $30,194 - $42,919	-274 Reduced 6.52%	3,928 $440,000
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $178,083 - $285,897	-1,766 Reduced 29.59%	4,202 $680,000
Q1 2021 May 14, 2021	SELL	$110.72 - $210.04 $462,256 - $876,917	-4,175 Reduced 41.16%	5,968 $727,000
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $52,422 - $113,985	658 Added 6.94%	10,143 $1.55 Million
Q3 2020 Nov 16, 2020	BUY	$78.5 - $100.64 $744,572 - $954,570	9,485 New	9,485 $793,000

Others Institutions Holding CRSP

# of Institutions

485

Shares Held

57.5M

Call Options Held

1.09M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.12B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Sarl with notifications on news.

Account

Capital International Sarl Crispr Therapeutics Ag Transaction History